| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/25/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
8-K
| Quarterly results |
| 06/07/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial S...|
Docs:
|
"Amendment to the Company’s Articles of Incorporation, filed on June 7, 2023",
"Flora Growth Corp. to Effect Reverse Stock Split FORT LAUDERDALE, FLORIDA & TORONTO, June 7, 2023 -- Flora Growth Corp. , a global cultivator, manufacturer, and distributor of cannabis products and brands, announces that it will effect a reverse stock split, which shall become effective on June 9, 2023 at a ratio of 1-for-20 . The Company has provided The Nasdaq Stock Market with the appropriate notice and the Company expects that its common shares will commence trading on a post-Reverse Stock Split basis at market open on June 9, 2023. The common shares will continue to trade on the Nasdaq Capital Market under the existing ticker “FLGC”. The new CUSIP number for the common shares is 339764201 and the new ISIN is CA3397642016. The Reverse Stock Split, within a ratio ranging between 1-for-5..." |
|
| 06/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/18/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/10/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/01/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/18/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
8-K
| Quarterly results |
| 01/30/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/06/2023 |
8-K
| Quarterly results |
| 01/06/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/27/2022 |
6-K
| Quarterly results |
| 12/13/2022 |
6-K
| Quarterly results |
| 12/09/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 12/01/2022 |
144
| Form 144 - Report of proposed sale of securities: |
| 11/28/2022 |
6-K
| Quarterly results |
| 10/24/2022 |
6-K
| Quarterly results |
| 10/06/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/23/2022 |
F-3
| Form F-3 - Registration statement by foreign private issuers: |
| 09/19/2022 |
6-K/A
| Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] |
| 09/16/2022 |
20-F/A
| Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] |
| 08/15/2022 |
6-K
| Quarterly results |
| 07/29/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/14/2022 |
6-K
| Quarterly results |
|